Hasil Pencarian  ::  Simpan CSV :: Kembali

"Aspek metabolik komplikasi DM tipe 2, khususnya penyakit kardiovaskular, telah banyak dibahas, namun aspek imunometabolik masih terbatas, sehingga sangat penting untuk memahami peran sistem imun dalam perkembangan komplikasi. Tujuan penelitian ini adalah untuk memahami peran subset monosit (CD14,CD16) dan mediator inflamasinya (IL-1β, IL-10) terhadap risiko penyakit kardiovaskular pada Pasien DM tipe 2. Subset monosit CD14, CD16 diperiksa menggunakan sampel kultur PBMC dan dianalisis menggunakan flow cytometry. Metode Multiplex Immunoassays digunakan untuk mengukur IL-1β, dan IL-10. Hasil penelitian ini, menunjukkan terdapat pola peningkatan subset monosit CD14+, CD16+ pada DM tipe 2, namun tidak berbeda secara signifikan. Peningkatan monosit CD14+,CD16+ lebih dari 6.8% berhubungan dengan peningkatan risiko penyakit kardiovaskular. Rasio mediator inflamasi IL-1β, sebelum dan sesudah stimulasi LPS secara signifikan lebih tinggi pada DM tipe 2 dibandingkan kontrol. Pada kondisi inflamasi, peningkatan IL-10 berespon terhadap stimulasi LPS, namun tidak mampu mengkompensasi peningkatan IL-1β, sehingga kecenderungan menjadi lebih hiperinflamasi pada DM tipe 2. Glukosa puasa merupakan penanda metabolik yang berhubungan dengan peningkatan monosit CD14+,CD16+.

---

The metabolic aspects of Type 2 Diabetes (T2D) complications, particularly cardiovascular disease, have been widely discussed, but the immunometabolic aspects are still limited, so it is critical to understand the role of the immune system in the development of complications. The objective of this study is to understand about the role of the monocyte subset (CD14,CD16) and its inflammatory mediators (IL-1β, IL-10) in the risk of CVD in T2D. CD14, CD16 monocyte subset was examined using PBMC culture samples and analyzed using flow cytometry. The Multiplex Immunoassays method was used to measure IL-1β and IL-10. This study shows there is an increase in the CD14+, CD16+ monocyte subset in type 2 diabetes, but it is not significantly related. An increase in CD14+,CD16+ monocytes of more than 6.8% is associated with an increased risk of CVD. The ratio of the inflammatory mediator IL-1β to basal conditions and LPS stimulation was significantly higher in T2D than in controls. In inflammatory conditions, the increase in IL-10 responds to LPS stimulation, but it is unable to compensate for the increase in IL-1β in T2D, so the tendency becomes more hyperinflammatory in type 2 DM. Fasting glucose is a metabolic marker associated with an increase in CD14+,CD16+ monocytes"

"Periodontal status is a periodontum condition evaluated by using plaque index, calculus index, gingival index and pocket index. The main mediator of periodontum inflammation is IL-113 examined by ELISA method. There is an evaluation of PMN s in periodontum inflammation, but the leucotoxin as well as the protease in turn lowers the PMN phagocytotic function. Phagocytotic function was measured by flowcytometry. The aim of the study was to evaluate the high risk factors of being type 2 DM. A diagnostic study was conducted by using cross-sectional design on 45 controlled DM (CDM) subjects, 45 uncontrolled DM (UCDM) subjects in the Metabolic Endocrinology Clinic Cipto Mangunkusumo Hospital Jakarta, as compared to 45 non-DM control subjects. The result of multivariate analysis showed that patients of older age (>54 years old), low periodontum status (periodontal index >1.80), high IL-113 level (>23.70 pg/mL), and low PMN phagocytotic function <<53.47%), were significantly at high risk of having DM compared to non-DM (p<0.05). Lower periodontum status showed an increase in IL-113 level, decrease PMN phagocytotic function, and consequently, an increase in the risk of being type 2 DM."

"Penerapan pedoman gizi kedalam menu sehari-hari merupakan tantangan bagi mayoritas pasien diabetes karena memerlukan penyesuaian dan kesukarelaan dari pasien untuk mengubah pola makan yang sudah lama terbentuk dan sering menimbulkan kejenuhan dan stress disebabkan pasien diabetes harus mengikuti program diet seumur hidupnya. Aktivitas self management serta respon psikologis memiliki pengaruh yang besar pada pasien diabetes melitus dalam melakukan usaha pengontrolan diet. Penelitian ini menggunakan desain cross sectional yang dilakukan di RSPAD Gatot Soebroto, RS Fatmawati dan RSUPN Dr. Cipto Mangunkusomo Jakarta dengan jumlah responden 260 orang pasien diabetes melitus tipe 2. Pengukuran respon psikologis menggunakan Problem Areas In Diabetes PAID, aktivitas self management diukur menggunakan Diabetes Self Management Questionare DMSQ yang telah dilakukan uji validitas dan reliabilitas serta pengukuran asupan makanan melalui kuesioner food recall 1x24 jam dan status nutrisi dinilai dengan indeks massa tubuh IMT. Hasil analisis menunjukkan terdapat hubungan bermakna antara respon psikologis dan status nutrisi p = 0,000, OR =4,944 , terdapat hubungan bermakna antara diabetes self management dengan status nutrisi p = 0,002, OR = 2,217 yang tidak dipengaruhi variabel perancu jenis OAD, asupan makanan, dan usia. Diperlukan penambahan materi konseling untuk memenuhi kebutuhan psikologis terkait diabetes serta penguatan edukasi secara berulang-ulang kepada pasien.

---

The application of nutritional guidelines into the daily menu is a challenge for the majority of diabetic patients because it requires adjustment and volunteering of patients to change the long established diet and often leads to saturation and stress because diabetic patients should follow a diet plan for the rest of their lives. Self management activities as well as psychological responses have a great influence on diabetes mellitus patients in doing diet control efforts. This research use cross sectional design which done in Gatot Soebroto army hospital, Fatmawati Hospital and Dr. Cipto Mangunkusomo hospital Jakarta with the number of respondents 260 people with type 2 diabetes mellitus. Measurement of psychological response using Problem Areas In Diabetes PAID, self management activity is measured using Diabetes Self Management Questionare DMSQ which has tested the validity and reliability and measurement of food intake through food recall questionnaire 1x24 hours and nutritional status assessed with body mass index BMI. The result showed that there was a significant correlation between psychological response and nutritional status p 0,000, OR 4,944 , there was a significant correlation between diabetes self management with nutritional status p 0,002, OR 2,217 unaffected by confounder type OAD, intake food, and age. Required addition of counseling material to meet the psychological needs related to diabetes as well as the strengthening of education repeatedly to the patient."

"ABSTRAKDiabetes Melitus Tipe 2 (DMT2) adalah masalah global yang sangat serius. Penyakit ini menyerang pada usia yang paling produktif sehingga dapat menurunkan derajat ekonomi dan mengurangi usia harapan hidup. Patogenesis DM sangat erat kaitannya dengan inflamasi, ditandai dengan peningkatan kadar sitokin proinflamasi seperti IL-6, IL-8 dan TNF. Namun, belum ada agen antiinflamasi yang terbukti berperan dalam tatalaksana DMT2. Butirat merupakan asam lemak rantai pendek yang diproduksi dari fermentasi pati resisten di lumen usus. Dalam kondisi normal butirat diserap dan digunakan sebagai sumber energi bagi sel kolonosit, hati dan otot. Butirat mampu berikatan dengan reseptor GPR41 dan GPR43 pada monosit sehingga mampu mengubah pola ekspresi sitokin, aktivasi, migrasi dan diferensiasi sel. Sehingga menarik untuk meneliti pengaruh butirat terhadap migrasi dan sitokin yang diekspresikan oleh monosit pada pasien DMT2. Kadar sitokin dihitung dari supernatan yang diambil dari kultur monosit . Sebanyak 37 subJek dibagi menjadi dua perlakuan yaitu kontrol dan dengan penambahan butirat. Monosit hari pertama diisolasi dalam gel kolagen tipe 1 untuk dilakukan uji migrasi menggunakan μ-slide chemotaxis IBIDI. Analisis gambar menggunakan software ImageJ dan Chemotaxis tool. Terdapat adanya perbedaan yang bermakna pada rasio TNF/IL 10 antara kelompok sehat dan DMT2. Butirat juga terlihat menekan produksi sitokin TNF dan meningkatkan produksi IL10. Indikator migrasi monosit seperti jarak akumulasi dan kecepatan migrasi memiliki perbedaan bermakna antara kelompok sehat dan DMT2. Butirat dapat menekan laju migrasi monosit diikuti dengan penurunan jarak dan kecepatan migrasi monosit

---

ABSTRACTType 2 Diabetes Mellitus (DMT2) is a very serious global problem. This disease attacks at the most productive age so that it can reduce economic status and reduce life expectancy. The pathogenesis of DM is very closely related to inflammation. characterized by increased levels of proinflammatory cytokines such as IL-6, IL-8 and TNF. However, no anti-inflammatory agent has been proven to play a role in the management of T2DM. Butyrate is a short chain fatty acid produced from resistant starch fermentation in the intestinal lumen. In normal conditions the butyrate is absorbed and used as an energy source for colonocytes, liver and muscle cells. Butirate is able to bind to GPR41 and GPR43 receptors on monocytes so that it can change the pattern of cytokine expression, activation, migration and cell differentiation. So it is interesting to examine the effect of butyrate on migration and cytokines expressed by monocytes in T2DM patients. Cytokine levels were calculated from supernatants taken from monocyte cultures. A total of 37 subjects were divided into two treatments, namely control and with addition of butyrate. The first day monocytes were isolated in type 1 collagen gel for migration testing using the slide chemotaxis IBIDI. Image analysis using ImageJ and Chemotaxis tool software. There was a significant difference in the TNFα / IL 10 ratio between healthy groups and T2DM. Butyrate also appears to suppress TNF cytokine production and increase IL10 production. Monocyte migration indicators such as accumulation distance and migration speed have significant differences between healthy groups and T2DM. Butirat can reduce inflammation responds and the distance and speed of monocyte migration"

"Diabetes mellitus tipe 2 (DMT2) adalah penyakit metabolik kronis, yang melibatkan berbagai macam proses patogenik. Secara keseluruhan pada seluruh proses tersebut menghasilkan hilangnya massa dan/atau fungsi dari sel - β pankreas yang dimanifestasikan sebagai hiperglikemia. Pengaruh faktor keluarga tampaknya terlibat dalam inisiasi dan perkembangan DMT2 melalui faktor genetik dan nongenetik. Lingkungan keluarga yang sama dengan pasien dengan diabetes, kerabat tingkat pertama pasien dengan diabetes menunjukkan peningkatan risiko 30-70% terkena diabetes. Resistensi insulin dan disfungsi sel telah diidentifikasi pada individu dengan riwayat keluarga diabetes, bahkan sebelum adanya muncul gejala DMT2. Monocyte chemoattractant protein-1 (MCP-1) adalah kemokin-CC dengan kemampuan efek atraktan untuk monosit, sel T memori dan basofil. Ekspresi dari MCP-1 jaringan adiposa dan kadar yang bersirkulasi berkorelasi positif dengan adipositas. Adiposit yang lebih besar dikaitkan dengan resistensi insulin. Penelitian ini bertujuan untuk mengetahui perubahan ekspresi MCP-1 terhadap monosit sebelum dan setelah perlakuan diet tinggi lemak selama lima hari. Hasilnya didapatkan adanya perubahan aktifitas inflamasi yang ditandai dengan rasio TNF-α/IL - 10 yang tinggi pada kelompok FDR sehingga dapat meningkatkan aktifitas MCP-1. Namun, idak ditemukan hubungan kadar MCP-1 serum dengan presentase monosit CD14+CD16+ baik pada kedua kelompok.

---

Type 2 diabetes mellitus is a chronic metabolic disease, which involves a variety of pathogenic processes. Overall these processes result in loss of mass and/or function of pancreatic -cells which is manifested as hyperglycemia. The influence of familial factors appears to be involved in the initiation and development of T2DM through both genetic and nongenetic factors. In the same family environment as patients with diabetes, first-degree relatives of patients with diabetes show a 30-70% increased risk of developing diabetes. Insulin resistance and cell dysfunction have been identified in individuals with a family history of diabetes, even before the onset of T2DM symptoms.

Monocyte chemoattractant protein-1 (MCP-1) is a CC-chemokine with an attractant effect on monocytes, memory T cells and basophils. Expression of adipose tissue MCP-1 and circulating levels were positively correlated with adiposity. Larger adipocytes are associated with insulin resistance. This study aims to determine the changes in MCP-1 expression on monocytes before and after treatment with a high-fat diet for five days. The results showed that there was a change in inflammatory activity which was indicated by a high ratio of TNF-α/IL - 10 in the FDR group so that it could increase MCP-1 activity. However, there was no relationship between serum MCP-1 levels and the percentage of CD14+CD16+ monocytes in both groups."

"Hingga tahun 2021 IDF melaporkan sekitar 537 juta orang dewasa hidup dengan diabetes dan diproyeksikan akan terus meningkat, serta 90% diantaranya adalah tipe 2. Salah satu faktor utama yang dapat menyebabkan risiko Diabetes melitus tipe 2 adalah polusi udara termasuk polutan PM2.5. Namun, penelitian dengan topik ini belum banyak diteliti terutama di Indonesia sehingga untuk menelaah lebih jauh penelitian ini dilakukan untuk mengetahui gambaran faktor-faktor terkait pajanan PM2.5 serta faktor individu dalam meningkatkan risiko kejadian Diabetes melitus tipe 2 berdasarkan kajian sistematis terhadap literatur. Sebanyak 12 literatur berupa artikel jurnal ilmiah dari berbagai negara yang dipublikasikan pada tahun 2013-2021 disintesis dalam penelitian ini. Berdasarkan kajian sistematis, diketahui bahwa faktor risiko pajanan PM2.5 jangka panjang, konsentrasi PM2.5 yang tinggi, dan tinggal pada daerah padat penduduk, dekat dengan jalan raya, serta pada daerah dengan aktivitas industri dapat meningkatkan risiko Diabetes melitus tipe 2. Kejadian ini kemudian dapat lebih berisiko pada populasi dengan usia lebih tua (>40 tahun) dan IMT kelebihan berat badan (25 kg/m3 -30 kg/m3) dan obesitas (≥30 kg/m3). Namun untuk faktor risiko jenis kelamin lebih banyak pada laki-laki dan pada yang sudah berhenti atau tidak pernah merokok, yang mana hasil ini merupakan penemuan baru yang berbeda dari teori dan penelitian sebelumnya sehingga perlu dilakukan penelitian lebih lanjut beserta faktor risiko lainnya.

---

Until 2021, the IDF reports that around 537 million adults live with diabetes and that number is projected to continue to increase, and 90% of them are type 2. One of the main factors that can increase the risk of type 2 Diabetes mellitus is air pollution, including PM2.5 pollutants. However, research on this topic has not been widely studied, especially in Indonesia, so to examine further, this study was conducted to determine the description of factors related to PM2.5 exposure and individual factors in increasing the risk of type 2 diabetes mellitus based on a systematic review of the literature. A total of 12 literatures in the form of scientific journal articles from various countries published in 2013-2021 were synthesized in this study. Based on a systematic study, it is known that the risk factors for long-term PM2.5 exposure, high PM2.5 concentrations, and living in densely populated areas, close to roads, and in areas with industrial activity can increase the risk of type 2 Diabetes mellitus. They may be more vulnerable in the population with an older age (> 40 years) and a BMI of overweight (25 kg/m3-30 kg/m3) or obese (30 kg/m3). However, the risk factors for sex are higher in men and in those who have stopped or have never smoked, which is a new finding that is different from previous theories and research, so further research needs to be done along with other risk factors."

"ABSTRAK Latar Belakang. Prevalensi disfungsi tiroid lebih tinggi pada pasien diabetes dibandingkan populasiumum. Hipotiroidisme memperburuk komplikasi, morbiditas, mortalitas, dan kualitas hidup pasiendiabetes melitus tipe 2 (DM tipe 2). Faktor risiko hipotiroidisme pada pasien DM tipe 2 selama ini masihkontradiktif dan belum dikaji secara lengkap. Keberadaan sistem skor hipotiroidisme pada pasien DMtipe 2 diperlukan untuk membantu diagnosis dan menapis pasien DM tipe 2 yang memerlukanpemeriksaan laboratorium fungsi tiroid sebagai baku emas diagnosis hipotiroidisme.Tujuan. Mengetahui prevalensi dan determinan hipotiroidisme pada pasien DM tipe 2.Metode. Penelitian dengan desain potong lintang dilakukan di Poliklinik Divisi Metabolik Endokrin(Poliklinik Diabetes) RSCM pada Juli sampai September 2015 dengan metode sampling konsekutif.Subjek menjalani anamnesis, pemeriksaan fisis, dan pemeriksaan laboratorium (TSH dan fT4). Analisisdata dilakukan dengan program statistik SPSS Statistics 17.0 untuk analisis univariat, bivariat,multivariat, dan Receiving Characteristics Operator (ROC) dan SPSS Statistics 20.0 untuk analisisbootstrapping pada Kalibrasi Hosmer-Lemeshow.Hasil. Sebanyak 303 subjek dianalisis untuk mendapatkan proporsi disfungsi tiroid dan 299 subjekdianalisis untuk mendapatkan determinan hipotiroidisme. Sebanyak 23 subjek (7,59%) terdiagnosishipotiroidisme, terdiri dari 43,5% subjek hipotiroid klinis dan 56,5% subjek hipotiroid subklinisberdasarkan Indeks Zulewski dan/atau Indeks Billewicz, dengan 16,7% hipotiroid klinis dan 83,3%hipotiroid subklinis berdasarkan hasil pemeriksaan fT4. Determinan hipotiroidisme pada pasien DMtipe 2 adalah riwayat penyakit tiroid di keluarga dengan OR sebesar 4,719 (95% IntervalKepercayaan/IK 1,07-20,8, p = 0,04), keberadaan goiter dengan OR sebesar 20,679 (95% IK 3,49122,66, p = 0,001),kontrol glikemik yang buruk dengan OR sebesar 3,460 (95%IK 1,075-11,14, p = 0,037), dan adanya sindrom metabolikOR sebesar 25,718 (95% IK 2,21-299,99, p = 0,01). Simpulan. Proporsi hipotiroidisme pada pasien DM tipe 2 adalah 7,59%. Determinan diagnosis dan komponen sistem skor hipotiroidisme pada pasien DM tipe 2 adalah riwayat penyakit tiroid di keluarga, keberadaan goiter, kontrol glikemik yang buruk, dan adanya sindrom metabolik. Sistem skor yang diberi nama Skor Hipotiroid RSCM ini diharapkan menjadi alat bantu diagnosis hipotiroidisme pada pasienDM tipe 2. ABSTRACT Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results. 303 subjects included for proportion study of thyroid dysfunction and 299subjects included for analysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01). Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients.;Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results.303subjectsincludedforproportionstudyofthyroiddysfunctionand299subjectsincludedforanalysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01).Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients.;Background. Prevalence of thyroid dysfunction is greater in diabetes patients compared to generalpopulation. Hypothyroidism is worsening complications, morbidity, mortality, and quality of life in type2 diabetes mellitus (T2DM) patients. Risk factors of hypothyroidism in T2DM patients are stillcontradictive and not assessed completely. Presence of scoring system to estimate hypothyroidism inT2DM patients are needed to help diagnosing and screening of T2DM patients who need to undergothyroid function test as a gold standard diagnostic for hypothyroidism.Aim. To identify prevalence and estimators of hypothyroidism in T2DM patients.Methods. A cross-sectional study was conducted in Metabolic Endocrine (Diabetes) Outpatient ClinicCipto Mangunkusumo Hospital from July-September 2015 with consecutive sampling method. Allsubjects underwent interview, physical examination, and laboratory testing (TSH and fT4). Analysiswas done by using SPSS Statistics 17.0 for univariate, bivariate, multivariate, and ROC (ReceivingOperator Characteristics) analysis and SPSS Statistics 20.0 for bootstrapping analysis in HosmerLemeshowCalibration. Results.303subjectsincludedforproportionstudyofthyroiddysfunctionand299subjectsincludedforanalysis of hypothyroidism determinants. 23 subjects (7,59%) are diagnosed as havinghypothyroidism, consisted of 43,5% clinical hypothyroidism and 56,5% subclinical hypothyroidismbased on clinical scoring index by Zulewski and Billewicz, and 16,7% subjects as having clinicalhypothyroidism and 83,3% subjects as having subclinical hypothyroidism based on fT4 examination.Determinants for hypothyroidism in T2DM patients are family history of thyroid disease with OR 4,719(95% Confident Interval/CI 1,07-20,8, p = 0,04), having goiter or difus struma with OR 20,679 (95%CI 3,49-122,66, p = 0,001), poor glycemic control with OR 3,460 (95% CI 1,075-11,14, p = 0,037), and metabolic syndrome with OR 25,718 (95% CI 2,21-299,99, p = 0,01).Conclusion. Proportion of hypothyroidism in T2DM patients is 7,59%. Determinants and componentsof scoring system of hypothyroidism in T2DM patients consist of family history of thyroid disease,having goiter or difus struma, poor glycemic control, and metabolic syndrome. Scoring system which iscalled RSCM Hypothyroid Score is expected to be a tool for helping diagnosis of hypothyroidism inT2DM patients."

"Latar belakang: Penderita diabetes melitus tipe 2 memiliki risiko yang lebih tinggi untuk mengalami karies gigi. Fosfat memegang peranan utama dalam kapasitas buffer unstimulated saliva sehingga kadar fosfat berhubungan dengan faktor risiko karies individu. Kondisi ketosis dan hiperparatiroidisme yang menyertai diabetes melitus tipe 2 dapat menyebabkan penurunan buffer fosfat tubuh yang kemudian menurunkan kadar fosfat dalam unstimulated saliva. Tujuan: Menganalisis kadar fosfat dalam unstimulated saliva pada pasien diabetes melitus tipe 2. Metode: Unstimulated saliva 15 subjek diabetes melitus tipe 2 dan 15 subjek non diabetes melitus dikumpulkan untuk kemudian diukur kadar fosfatnya dengan metode phosphomolydate pada alat UV-Vis Spectrophotometer. Hasil: Terdapat perbedaan kadar fosfat yang bermakna (p < 0,05) antara subjek uji dan subjek kontrol. Kesimpulan: Kadar fosfat dalam unstimulated saliva pada pasien diabetes melitus tipe 2 (0,27 ± 0,05 mmol/L) lebih rendah jika dibandingkan dengan individu non diabetes melitus (2,16 ± 0,22 mmol/L) yang mana berdasarkan analisis statistik, hal tersebut berbeda bermakna secara signifikan.

---

Background: Type 2 diabetes mellitus patients have a higher risk to suffer from dental caries. Phosphate plays a primary role in buffer capacity of unstimulated saliva so that phosphate concentration is associated with individual caries risk factors. Ketosis and Hyperparathyroidism conditions that come within type 2 Diabetes Mellitus could decrease the phosphate buffer in the body which then will decrease the phosphate concentration in unstimulated saliva.

Objective: To analyze the phosphate concentration in unstimulated saliva of type 2 diabetes mellitus patients.

Method: Unstimulated saliva of 15 type 2 diabetes mellitus subjects and 15 non-diabetic subjects were collected and then the concentration of phosphate was measured by the phosphomolydate method on UV-Vis Spectrophotometer instrument.

Result: There were significant differences in the phosphate concentration (p <0.05) between test subjects and control subjects.

Conclusion: The phosphate concentration in unstimulated saliva of type 2 diabetes mellitus patients (0.27 ± 0.05 mmol / L) is lower than individuals without diabetes mellitus (2.16 ± 0.22 mmol / L), which is significantly different by statistical analysis."